Metástasis suprarrenal metacrónica en 2 pacientes sometidos a nefrectomía radical por carcinoma de células renales primario

Rosales Leal, José Luis; Rodríguez Herrera, Francisco; Ortiz Gorráiz, Manuel; Honrubia Vílchez, Beatriz; Fernández Sánchez, Antonio; Vázquez Alonso, Fernando; Pascual Geler, Manrique; Martínez Morcillo, Antonio; Vicente Prados, Javier; Cózar Olmo, José Manuel; Espejo Maldonado, Eduardo; Tallada Buñuel, Miguel.
Arch. esp. urol. (Ed. impr.) ; 59(8): 779-784, oct. 2006. ilus
Artículo en Español | IBECS (España) | ID: ibc-135599

Documentos relacionados

  1. Multi-regional Sequencing Elucidates the Evolution of Clear Cell Renal Cell Carcinoma.
  2. Heavy Metal Enlightens Tumor Immunity.
  3. Cytoreductive surgery, systemic treatment, genetic evaluation, and patient perspective in a young adult with metastatic renal cell carcinoma.
  4. Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell Carcinoma.
  5. Outcomes of Localized Renal Cell Carcinoma Across Different Races.
  6. Surgical and focal treatment for metastatic renal cell carcinoma: A literature review.
  7. Papillary Renal Cell Carcinoma: Evolving Classification by Combined Morphologic and Molecular Means.
  8. Prognostic value of the ratio of maximum to minimum diameter of primary tumor in metastatic clear cell renal cell carcinoma.
  9. Molecular differences in renal cell carcinoma between males and females.
  10. Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome.